NCT07079072Not yet recruiting
Acupuncture for Lung Cancer-Related Fatigue
The Effects of Acupuncture for Lung Cancer-Related Fatigue, a Clinical Trial
Source: ClinicalTrials.gov · Last updated 25 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study aims to evaluate the efficacy and safety of acupuncture in alleviating cancer-related fatigue (CRF) among lung cancer survivors. It addresses the key issue of limited high-quality evidence for acupuncture's effect on CRF by rigorously comparing real acupuncture against a non-penetrating sham needle control in 120 eligible participants. Patients will be centrally randomized (1:1), blinded, and receive 12-session treatment over 4 weeks. Participants will complete treatment and attend follow-up visits up to week 16, and repeatedly complete fatigue (BFI-C, MFI-20), psychological (PHQ-9, GAD-7, FCRI), functional (CWSAS), and sleep (ISI) assessments.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- First submitted
- 13 Jul 2025
- Start date
- 1 Aug 2025
- Primary completion date
- 30 Sept 2026
- Lead sponsor
- Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Diseases
- Lung cancer
- NCT number
- NCT07079072
What you commit to
- Study type: Interventional
- Planned participants: 120
- From 1 Aug 2025 to the primary completion date, 30 Sept 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients experiencing significant fatigue symptoms before being diagnosed with lung cancer;
- Patients showing notable cognitive impairment or suicidal tendencies;
- Patients with a history of hypothyroidism or chronic fatigue syndrome;
- Patients with serious sleep disorders;
- Patients who have undergone acupuncture treatment for cancer-related fatigue within the past month;
- Patients with uncontrolled severe underlying conditions, such as heart failure, myocardial infarction, unstable angina, endocrine disorders, gastrointestinal issues, neurological impairments, severe infections, liver and kidney failure, or chronic obstructive pulmonary disease;
Lab values
- Patients suffering from moderate to severe anemia, with hemoglobin levels below 90 g/L;
Other
- Patients with severe anxiety and depression;
- Patients experiencing severe pain, with a Numeric Rating Scale (NRS) score of 7 or higher;
- Patients with severe malnutrition;
- Patients with seriously diminished physical function;
- Patients with poor adherence;
- Patients who are breastfeeding, pregnant, or planning to conceive within the next four months.
Who the study is looking for
- Patients with a history of lung cancer who have completed initial treatment (including surgery, radiotherapy, and/or chemotherapy) at least 8 weeks prior;
- Aged between 18 and 75 years;
- Meet the diagnostic criteria for cancer-related fatigue;
- Estimated to have a survival period of at least 3 months;
- Patients with moderate to severe cancer-related fatigue (the highest fatigue score in the past 24 hours on the Chinese version of the Brief Fatigue Inventory \[BFI-C\] ≥ 4 points);
- ECOG Performance Status score ranges from 0 to 2 points
- Voluntarily join this study and sign the informed consent form.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.